These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36016551)

  • 1. Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors.
    Dávila EM; Patricio F; Rebolledo-Bustillo M; Garcia-Gomez D; Hernandez JCG; Sanchez-Gaytan BL; Limón ID; Perez-Aguilar JM
    Front Pharmacol; 2022; 13():945935. PubMed ID: 36016551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
    Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
    Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach.
    Walsh SK; Hepburn CY; Keown O; Åstrand A; Lindblom A; Ryberg E; Hjorth S; Leslie SJ; Greasley PJ; Wainwright CL
    Pharmacol Res Perspect; 2015 Jun; 3(3):e00143. PubMed ID: 26236485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
    Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
    Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
    Jakowiecki J; Abel R; Orzeł U; Pasznik P; Preissner R; Filipek S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of mesenchymal stem cell migration by cannabidiol via activation of p42/44 MAPK.
    Schmuhl E; Ramer R; Salamon A; Peters K; Hinz B
    Biochem Pharmacol; 2014 Feb; 87(3):489-501. PubMed ID: 24304686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
    McHugh D; Hu SS; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB
    BMC Neurosci; 2010 Mar; 11():44. PubMed ID: 20346144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.
    Li K; Fichna J; Schicho R; Saur D; Bashashati M; Mackie K; Li Y; Zimmer A; Göke B; Sharkey KA; Storr M
    Neuropharmacology; 2013 Aug; 71(100):255-63. PubMed ID: 23603203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB
    Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH
    Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
    Sartim AG; Guimarães FS; Joca SR
    Behav Brain Res; 2016 Apr; 303():218-27. PubMed ID: 26801828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism.
    Gavryushov S; Bashilov A; Cherashev-Tumanov KV; Kuzmich NN; Burykina TI; Izotov BN
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner.
    Kolbe MR; Hohmann T; Hohmann U; Ghadban C; Mackie K; Zöller C; Prell J; Illert J; Strauss C; Dehghani F
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33802282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR55: a new member of the cannabinoid receptor clan?
    Pertwee RG
    Br J Pharmacol; 2007 Dec; 152(7):984-6. PubMed ID: 17876300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB
    Khan AU; Falconi-Sobrinho LL; Dos Anjos-Garcia T; de Fátima Dos Santos Sampaio M; de Souza Crippa JA; Menescal-de-Oliveira L; Coimbra NC
    Psychopharmacology (Berl); 2020 Apr; 237(4):1063-1079. PubMed ID: 31919563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB
    Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ
    Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
    McPartland JM; Duncan M; Di Marzo V; Pertwee RG
    Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments.
    Bayer H; Stern CAJ; Troyner F; Gazarini L; Guimarães FS; Bertoglio LJ
    Neuropharmacology; 2022 Mar; 205():108913. PubMed ID: 34864001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.
    Silva NR; Gomes FV; Fonseca MD; Mechoulam R; Breuer A; Cunha TM; Guimarães FS
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):369-377. PubMed ID: 28720466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.